New diabetes clinical trial: SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF

Published on: June 03, 2024 at 11:00PM
Conditions: Heart Failure Acute; Diabetes Type 2; Heart Failure With Reduced Ejection Fraction; Heart Failure With Preserved Ejection Fraction
Interventions: Drug: Dapagliflozin tablet; Drug: Hypertonic Saline Solution, 1 Ml; Drug: Furosemide Injection
Sponsors: University of Palermo
Not yet recruiting
https://ift.tt/HF6ys7P